Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)
April 25, 2023 03:00 PM EDT
Deals
Manufacturing

Serum In­sti­tute sub­sidiary in­vests an­oth­er $150M in­to Bio­con

Tyler Patchen

News Reporter

Biosim­i­lar man­u­fac­tur­er Bio­con said Tues­day that the Serum In­sti­tute of In­dia is mak­ing an­oth­er $150 mil­lion in­vest­ment, dou­bling a pri­or in­vest­ment from last No­vem­ber. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times